Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 4
2013 3
2014 2
2015 3
2016 2
2017 1
2018 1
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer.
Duro-Sánchez S, Nadal-Serrano M, Lalinde-Gutiérrez M, Arenas EJ, Bernadó Morales C, Morancho B, Escorihuela M, Pérez-Ramos S, Escrivá-de-Romaní S, Gandullo-Sánchez L, Pandiella A, Esteve-Codina A, Rodilla V, Dijcks FA, Dokter WHA, Cortés J, Saura C, Arribas J. Duro-Sánchez S, et al. Among authors: nadal serrano m. Cancer Res. 2022 Dec 16;82(24):4670-4679. doi: 10.1158/0008-5472.CAN-22-0787. Cancer Res. 2022. PMID: 36222720 Free PMC article.
Vitamin D analogues exhibit antineoplastic activity in breast cancer patient-derived xenograft cells.
Ferronato MJ, Nadal Serrano M, Arenas Lahuerta EJ, Bernadó Morales C, Paolillo G, Martinez-Sabadell Aliguer A, Santalla H, Mascaró M, Vitale C, Fall Y, Arribas J, Facchinetti MM, Curino AC. Ferronato MJ, et al. Among authors: nadal serrano m. J Steroid Biochem Mol Biol. 2021 Apr;208:105735. doi: 10.1016/j.jsbmb.2020.105735. Epub 2020 Aug 9. J Steroid Biochem Mol Biol. 2021. PMID: 32784045
The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1.
Nadal-Serrano M, Morancho B, Escrivá-de-Romaní S, Morales CB, Luque A, Escorihuela M, Espinosa Bravo M, Peg V, Dijcks FA, Dokter WHA, Cortés J, Saura C, Arribas J. Nadal-Serrano M, et al. Cancers (Basel). 2020 Mar 13;12(3):670. doi: 10.3390/cancers12030670. Cancers (Basel). 2020. PMID: 32183023 Free PMC article.
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells.
Cordani M, Butera G, Dando I, Torrens-Mas M, Butturini E, Pacchiana R, Oppici E, Cavallini C, Gasperini S, Tamassia N, Nadal-Serrano M, Coan M, Rossi D, Gaidano G, Caraglia M, Mariotto S, Spizzo R, Roca P, Oliver J, Scupoli MT, Donadelli M. Cordani M, et al. Among authors: nadal serrano m. Br J Cancer. 2018 Oct;119(8):994-1008. doi: 10.1038/s41416-018-0288-2. Epub 2018 Oct 15. Br J Cancer. 2018. PMID: 30318520 Free PMC article.
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.
Cordani M, Oppici E, Dando I, Butturini E, Dalla Pozza E, Nadal-Serrano M, Oliver J, Roca P, Mariotto S, Cellini B, Blandino G, Palmieri M, Di Agostino S, Donadelli M. Cordani M, et al. Among authors: nadal serrano m. Mol Oncol. 2016 Aug;10(7):1008-29. doi: 10.1016/j.molonc.2016.04.001. Epub 2016 Apr 12. Mol Oncol. 2016. PMID: 27118659 Free PMC article.
19 results